1.485
price down icon10.00%   -0.165
 
loading
Evogene Ltd stock is traded at $1.485, with a volume of 123.88K. It is down -10.00% in the last 24 hours and down -42.44% over the past month. Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
See More
Previous Close:
$1.65
Open:
$1.61
24h Volume:
123.88K
Relative Volume:
0.46
Market Cap:
$9.01M
Revenue:
$5.64M
Net Income/Loss:
$-23.88M
P/E Ratio:
-2.70
EPS:
-0.55
Net Cash Flow:
$-22.36M
1W Performance:
-15.14%
1M Performance:
-42.44%
6M Performance:
-79.52%
1Y Performance:
-76.43%
1-Day Range:
Value
$1.44
$1.64
1-Week Range:
Value
$1.44
$1.78
52-Week Range:
Value
$1.44
$10.40

Evogene Ltd Stock (EVGN) Company Profile

Name
Name
Evogene Ltd
Name
Phone
-
Name
Address
-
Name
Employee
143
Name
Twitter
@evogene_ltd
Name
Next Earnings Date
2024-11-10
Name
Latest SEC Filings
Name
EVGN's Discussions on Twitter

Compare EVGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
EVGN 1.4701 9.01M 5.64M -23.88M -22.36M -0.55
VRTX 447.47 115.74B 10.63B -479.80M -1.35B 13.33
REGN 744.21 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 592.97 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 248.92 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 103.87 24.49B 3.30B -501.07M 1.03B 11.54

Evogene Ltd Stock (EVGN) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-08-21 Initiated ROTH Capital Buy
Jul-29-21 Initiated Aegis Capital Buy
Dec-01-20 Initiated Cantor Fitzgerald Overweight
Dec-16-13 Initiated Oppenheimer Outperform

Evogene Ltd Stock (EVGN) Latest News

pulisher
10:23 AM

Evogene earnings missed by $0.30, revenue fell short of estimates - Investing.com India

10:23 AM
pulisher
07:59 AM

Evogene Sees Revenue Growth and Expands AI Collaboration - TipRanks

07:59 AM
pulisher
07:30 AM

Evogene Reports Third Quarter 2024 Financial Results - PR Newswire

07:30 AM
pulisher
Nov 19, 2024

Lavie Bio Advances its Bio-Fungicide LAV321, Targeting Downy Mildew, to Pre-Commercial Stage Following Successful 2024 Field Trial Results - Marketscreener.com

Nov 19, 2024
pulisher
Nov 19, 2024

Evogene's Bio-Fungicide Shows 70% Efficacy in Trials, Advances to Pre-Commercial Stage | EVGN Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 15, 2024

Evogene stock hits 52-week low at $1.7 amid market challenges - Investing.com India

Nov 15, 2024
pulisher
Nov 12, 2024

Evogene subsidiary Lavie Bio announces commercial expansion of Yalos treatment - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Finansavisen - Finansavisen

Nov 12, 2024
pulisher
Nov 07, 2024

Evogene Schedules Third Quarter 2024 Financial Results Release - Marketscreener.com

Nov 07, 2024
pulisher
Nov 07, 2024

Evogene (EVGN) to Report Q3 2024 Results, Hosts Virtual Conference Call Nov 21 | EVGN Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 04, 2024

Evogene Announces Collaboration with Google Cloud to Pioneer Generative AI Foundation Model for Novel Small Molecule Design - Krishak Jagat English

Nov 04, 2024
pulisher
Nov 01, 2024

Evogene and Google Cloud Partner to Develop AI Foundation Model for Drug Discovery - HIT Consultant

Nov 01, 2024
pulisher
Nov 01, 2024

Evogene stock hits 52-week low at $2.13 amid market challenges - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

500: Something went wrong - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Evogene partners with Google Cloud for AI-driven molecule design By Investing.com - Investing.com Australia

Nov 01, 2024
pulisher
Nov 01, 2024

Evogene partners with Google Cloud for AI-driven molecule design - Investing.com India

Nov 01, 2024
pulisher
Oct 31, 2024

Biomica to Present at Digestive Disease Week (DDW) Conference 20 - GuruFocus.com

Oct 31, 2024
pulisher
Oct 31, 2024

Evogene announces collaboration with Google Cloud - MSN

Oct 31, 2024
pulisher
Oct 30, 2024

Syngenta and Lavie Bio Announce Partnership to Discover and Deve - GuruFocus.com

Oct 30, 2024
pulisher
Oct 30, 2024

Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya - Krishak Jagat English

Oct 30, 2024
pulisher
Oct 26, 2024

Evogene Ltd. (NASDAQ:EVGN) Sees Significant Growth in Short Interest - MarketBeat

Oct 26, 2024
pulisher
Oct 25, 2024

Evogene (NASDAQ:EVGN) Stock Crosses Below 200-Day Moving AverageShould You Sell? - MarketBeat

Oct 25, 2024
pulisher
Oct 25, 2024

StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - MarketBeat

Oct 25, 2024
pulisher
Oct 18, 2024

Evogene stock hits 52-week low at $2.21 amid market challenges - Investing.com Nigeria

Oct 18, 2024
pulisher
Oct 17, 2024

Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - MarketBeat

Oct 17, 2024
pulisher
Oct 16, 2024

Watershed, Evogene, and BGU to Expand Gene Editing Applications to White Leg Shrimp and Red Swamp Crayfish - ISAAA

Oct 16, 2024
pulisher
Oct 09, 2024

Evogene (NASDAQ:EVGN) Shares Pass Below Two Hundred Day Moving AverageHere's What Happened - MarketBeat

Oct 09, 2024
pulisher
Oct 09, 2024

Evogene (NASDAQ:EVGN) Research Coverage Started at StockNews.com - MarketBeat

Oct 09, 2024
pulisher
Oct 08, 2024

Watershed AC, Evogene and Ben-Gurion University Receive Approval for Second Year Grant to Continue the Collaboration Focused on Improving Crustacean Traits Utilizing Gene Editing Technology - PR Newswire

Oct 08, 2024
pulisher
Oct 03, 2024

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of ‘MicroFermentor’, a Unique Technology that Can Change the Economics of Ag-Biologicals - Krishak Jagat English

Oct 03, 2024
pulisher
Oct 02, 2024

Lavie Bio receives grant to advance ag-biologicals tech - World Bio Market Insights

Oct 02, 2024
pulisher
Oct 01, 2024

Evogene (NASDAQ:EVGN) Stock Price Crosses Below 200 Day Moving Average of $5.81 - MarketBeat

Oct 01, 2024
pulisher
Oct 01, 2024

StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals - Lelezard

Sep 30, 2024
pulisher
Sep 30, 2024

Evogene receives grant from IIA to advance development of ‘MicroFermentor’ - TipRanks

Sep 30, 2024
pulisher
Sep 30, 2024

Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals – Company AnnouncementFT.com - Financial Times

Sep 30, 2024
pulisher
Sep 24, 2024

Evogene stock hits 52-week low at $2.6 amid market challenges - Investing.com Canada

Sep 24, 2024
pulisher
Sep 20, 2024

Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories - GuruFocus.com

Sep 20, 2024
pulisher
Sep 20, 2024

Biomica CEO Set to Attend JP Morgan Healthcare Week in San Franc - GuruFocus.com

Sep 20, 2024
pulisher
Sep 19, 2024

Casterra Appoints New CEO and Expands Team to Drive Growth and I - GuruFocus.com

Sep 19, 2024
pulisher
Sep 19, 2024

A Tale of Resilience: Evolv Technologies Holdings Inc Amid Stock Market Turbulence - The InvestChronicle

Sep 19, 2024
pulisher
Sep 19, 2024

Evotec (NASDAQ:EVO) Sees Unusually-High Trading Volume - MarketBeat

Sep 19, 2024

Evogene Ltd Stock (EVGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):